From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA approval of Utibron Neohaler is great news for COPD patients

from By Dr. Abimbola Farinde

Chronic obstructive pulmonary disease, or COPD, is regarded as a progressive and life-threatening lung disease that can make it a challenging for an individual to breathe. There are a variety of respiratory agents for the management of COPD, and the recent FDA approval of Utibron Neohaler offers another option. Utibron Neohaler is an important approval as it offers a new dual-action bronchodilator option for patients and the potential for better quality of life. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063